Ascendis Pharma A/S (ASND) Q1 2025 Earnings

1MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-2.06
-1.6
-1.14
-0.68

Details

Expected EPS
-1.51
Actual EPS
-1.66
Surprise EPS
-0.15
Surprise Percent
+9.93%

Description

Ascendis Pharma A/S (ASND) has reported earnings of -1.66 per share for Q1 2025.

0 Comments

Share your thoughts